Apyx Medical up on upbeat forecast

Apyx Medical

12/08/2021 17:43

** Shares of medical device maker  APYX.O  up 16.9% at
$10.70
    ** Co sees FY 2021 revenue between $40.6 mln and $42.6 mln;
analysts were estimating $38.7 mln
    ** Increasing 2021 revenue outlook to reflect both
stronger-than-expected Q2 sales performance and improved
expectations for H2 of 2021 - CEO Charlie Goodwin
    ** Co posts better-than-expected Q2 revenue, helped by
higher demand for its Advanced Energy products  urn:newsml:reuters.com:*:nBwbgqv0ca
    ** Q2 revenue rises ~161% to $11.2 mln vs estimates of $8.9
mln - Refinitiv IBES data
    ** Brokerage Piper Sandler raises PT to $14 from $12
    ** Stock up ~49% YTD

 (Reporting by Mrinalika Roy in Bengaluru)
 ((mrinalika.roy@thomsonreuters.com))